Literature DB >> 19713981

Nonalcoholic fatty liver disease: Disease and comorbidity--effects on quality of life.

Giulio Marchesini, Giampaolo Bianchi.   

Abstract

Nonalcoholic fatty liver disease has long been neglected by health-care professionals unless affected patients develop cirrhosis; however, new research shows this disease impairs health-related quality of life. The association of nonalcoholic fatty liver disease with chronic metabolic diseases and cardiovascular complications restricts our ability to define a specific role for liver damage in the poor perceived health status of these patients.

Entities:  

Mesh：

Year:  2009        PMID： 19713981     DOI： 10.1038/nrgastro.2009.142

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


  9 in total

1.  Health-related quality of life in patients with non-alcoholic fatty liver disease.

Authors:  A A Dan; J B Kallman; A Wheeler; Z Younoszai; R Collantes; S Bondini; L Gerber; Z M Younossi
Journal:  Aliment Pharmacol Ther       Date:  2007-09-15       Impact factor: 8.171

2.  Factors associated with poor health-related quality of life of patients with cirrhosis.

Authors:  G Marchesini; G Bianchi; P Amodio; F Salerno; M Merli; C Panella; C Loguercio; G Apolone; M Niero; R Abbiati
Journal:  Gastroenterology       Date:  2001-01       Impact factor: 22.682

3.  A comparison of global versus disease-specific quality-of-life measures in patients with NIDDM.

Authors:  R M Anderson; J T Fitzgerald; K Wisdom; W K Davis; R G Hiss
Journal:  Diabetes Care       Date:  1997-03       Impact factor: 19.112

4.  Construct validity of the Short Form-36 Health Survey and its relationship with BMI in obese outpatients.

Authors:  Francesco Corica; Andrea Corsonello; Giovanni Apolone; Maria Lucchetti; Nazario Melchionda; Giulio Marchesini
Journal:  Obesity (Silver Spring)       Date:  2006-08       Impact factor: 5.002

5.  Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.

Authors:  Giulio Marchesini; Elisabetta Bugianesi; Gabriele Forlani; Fernanda Cerrelli; Marco Lenzi; Rita Manini; Stefania Natale; Ester Vanni; Nicola Villanova; Nazario Melchionda; Mario Rizzetto
Journal:  Hepatology       Date:  2003-04       Impact factor: 17.425

6.  Long-term follow-up of patients with NAFLD and elevated liver enzymes.

Authors:  Mattias Ekstedt; Lennart E Franzén; Ulrik L Mathiesen; Lars Thorelius; Marika Holmqvist; Göran Bodemar; Stergios Kechagias
Journal:  Hepatology       Date:  2006-10       Impact factor: 17.425

7.  Fatigue in non-alcoholic fatty liver disease (NAFLD) is significant and associates with inactivity and excessive daytime sleepiness but not with liver disease severity or insulin resistance.

Authors:  J L Newton; D E J Jones; E Henderson; L Kane; K Wilton; A D Burt; C P Day
Journal:  Gut       Date:  2008-02-12       Impact factor: 23.059

8.  Host- rather than virus-related factors reduce health-related quality of life in hepatitis C virus infection.

Authors:  B Helbling; K Overbeck; J-J Gonvers; R Malinverni; J-F Dufour; J Borovicka; M Heim; A Cerny; F Negro; S Bucher; M Rickenbach; E L Renner; B Mullhaupt
Journal:  Gut       Date:  2008-07-14       Impact factor: 23.059

9.  Quality of life in adults with nonalcoholic fatty liver disease: baseline data from the nonalcoholic steatohepatitis clinical research network.

Authors:  Kristin David; Kris V Kowdley; Aynur Unalp; Fasiha Kanwal; Elizabeth M Brunt; Jeffrey B Schwimmer
Journal:  Hepatology       Date:  2009-06       Impact factor: 17.425
  9 in total
  1 in total

1.  Health-related quality of life and patient-reported outcome measures in NASH-related cirrhosis.

Authors:  Lorraine McSweeney; Matthew Breckons; Gulnar Fattakhova; Yemi Oluboyede; Luke Vale; Laura Ternent; Maria-Magdalena Balp; Lynda Doward; Clifford A Brass; Fiona Beyer; Arun Sanyal; Quentin M Anstee
Journal:  JHEP Rep       Date:  2020-03-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.